These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31554661)

  • 1. Mitochondrial amidoxime-reducing component 2 (MARC2) has a significant role in
    Rixen S; Havemeyer A; Tyl-Bielicka A; Pysniak K; Gajewska M; Kulecka M; Ostrowski J; Mikula M; Clement B
    J Biol Chem; 2019 Nov; 294(46):17593-17602. PubMed ID: 31554661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of mitochondrial amidoxime reducing components 1 and 2 and mitochondrial cytochrome b5 in N-reductive metabolism in human cells.
    Plitzko B; Ott G; Reichmann D; Henderson CJ; Wolf CR; Mendel R; Bittner F; Clement B; Havemeyer A
    J Biol Chem; 2013 Jul; 288(28):20228-37. PubMed ID: 23703616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of protein variants encoded by nonsynonymous single nucleotide polymorphisms in MARC1 and MARC2 in healthy Caucasians.
    Ott G; Reichmann D; Boerger C; Cascorbi I; Bittner F; Mendel RR; Kunze T; Clement B; Havemeyer A
    Drug Metab Dispos; 2014 Apr; 42(4):718-25. PubMed ID: 24423752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mammalian molybdenum enzymes of mARC.
    Ott G; Havemeyer A; Clement B
    J Biol Inorg Chem; 2015 Mar; 20(2):265-75. PubMed ID: 25425164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial Amidoxime Reducing Component (mARC) is involved in detoxification of N-hydroxylated base analogues.
    Krompholz N; Krischkowski C; Reichmann D; Garbe-Schönberg D; Mendel RR; Bittner F; Clement B; Havemeyer A
    Chem Res Toxicol; 2012 Nov; 25(11):2443-50. PubMed ID: 22924387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interindividual Variability and Differential Tissue Abundance of Mitochondrial Amidoxime Reducing Component Enzymes in Humans.
    Ahire D; Basit A; Christopher LJ; Iyer R; Leeder JS; Prasad B
    Drug Metab Dispos; 2022 Mar; 50(3):191-196. PubMed ID: 34949674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-reductive system composed of mitochondrial amidoxime reducing component (mARC), cytochrome b5 (CYB5B) and cytochrome b5 reductase (CYB5R) is regulated by fasting and high fat diet in mice.
    Jakobs HH; Mikula M; Havemeyer A; Strzalkowska A; Borowa-Chmielak M; Dzwonek A; Gajewska M; Hennig EE; Ostrowski J; Clement B
    PLoS One; 2014; 9(8):e105371. PubMed ID: 25144769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detoxification of Trimethylamine N-Oxide by the Mitochondrial Amidoxime Reducing Component mARC.
    Schneider J; Girreser U; Havemeyer A; Bittner F; Clement B
    Chem Res Toxicol; 2018 Jun; 31(6):447-453. PubMed ID: 29856598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran.
    Neve EP; Köfeler H; Hendriks DF; Nordling Å; Gogvadze V; Mkrtchian S; Näslund E; Ingelman-Sundberg M
    PLoS One; 2015; 10(9):e0138487. PubMed ID: 26378779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fourth mammalian molybdenum enzyme mARC: current state of research.
    Havemeyer A; Lang J; Clement B
    Drug Metab Rev; 2011 Nov; 43(4):524-39. PubMed ID: 21942410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pivotal role of the mitochondrial amidoxime reducing component 2 in protecting human cells against apoptotic effects of the base analog N6-hydroxylaminopurine.
    Plitzko B; Havemeyer A; Kunze T; Clement B
    J Biol Chem; 2015 Apr; 290(16):10126-35. PubMed ID: 25713076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Involvement of the Mitochondrial Amidoxime Reducing Component (mARC) in the Reductive Metabolism of Hydroxamic Acids.
    Ginsel C; Plitzko B; Froriep D; Stolfa DA; Jung M; Kubitza C; Scheidig AJ; Havemeyer A; Clement B
    Drug Metab Dispos; 2018 Oct; 46(10):1396-1402. PubMed ID: 30045842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrite reductase and nitric-oxide synthase activity of the mitochondrial molybdopterin enzymes mARC1 and mARC2.
    Sparacino-Watkins CE; Tejero J; Sun B; Gauthier MC; Thomas J; Ragireddy V; Merchant BA; Wang J; Azarov I; Basu P; Gladwin MT
    J Biol Chem; 2014 Apr; 289(15):10345-10358. PubMed ID: 24500710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitochondrial amidoxime reducing component (mARC): involvement in metabolic reduction of N-oxides, oximes and N-hydroxyamidinohydrazones.
    Jakobs HH; Froriep D; Havemeyer A; Mendel RR; Bittner F; Clement B
    ChemMedChem; 2014 Oct; 9(10):2381-7. PubMed ID: 25045021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mitochondrial amidoxime reducing component-from prodrug-activation mechanism to drug-metabolizing enzyme and onward to drug target.
    Struwe MA; Scheidig AJ; Clement B
    J Biol Chem; 2023 Nov; 299(11):105306. PubMed ID: 37778733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of Hydrogen Peroxide by Human Mitochondrial Amidoxime Reducing Component Enzymes.
    Rixen S; Indorf PM; Kubitza C; Struwe MA; Klopp C; Scheidig AJ; Kunze T; Clement B
    Molecules; 2023 Aug; 28(17):. PubMed ID: 37687214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mitochondrial amidoxime-reducing component (mARC1) is a novel signal-anchored protein of the outer mitochondrial membrane.
    Klein JM; Busch JD; Potting C; Baker MJ; Langer T; Schwarz G
    J Biol Chem; 2012 Dec; 287(51):42795-803. PubMed ID: 23086957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of human mARC1 reveals its exceptional position among eukaryotic molybdenum enzymes.
    Kubitza C; Bittner F; Ginsel C; Havemeyer A; Clement B; Scheidig AJ
    Proc Natl Acad Sci U S A; 2018 Nov; 115(47):11958-11963. PubMed ID: 30397129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC).
    Ott G; Plitzko B; Krischkowski C; Reichmann D; Bittner F; Mendel RR; Kunze T; Clement B; Havemeyer A
    Chem Res Toxicol; 2014 Oct; 27(10):1687-95. PubMed ID: 25170804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The History of mARC.
    Clement B; Struwe MA
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.